Advertisement

Topics

bioLytical Launches INSTI HIV Self Test for African Market in Response to New WHO Guidelines

09:36 EST 1 Dec 2016 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
RICHMOND, BC, Dec. 1, 2016 /PRNewswire/ - bioLytical Laboratories (the "Company"), a world leader in rapid infectious disease tests, announced today it is expanding the launch of its INSTI HIV Self Test to Africa with a lower cost version starting this mon...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "bioLytical Launches INSTI HIV Self Test for African Market in Response to New WHO Guidelines"

Quick Search
Advertisement
 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...